Novavax (NVAX) Stock Up 8% as FDA Approves Updated Covid Vaccine
The updated vaccine specifically addresses the XBB.1.5 subvariant of the Omicron variant, which has raised concerns due to its potential ...
Read moreThe updated vaccine specifically addresses the XBB.1.5 subvariant of the Omicron variant, which has raised concerns due to its potential ...
Read moreMerck is seeking authorization for emergency use of molnupiravir, an oral administration for early-stage COVID-19 patients. It is in talks ...
Read moreRegardless of the heated debates on the drug’s efficacy, Biogen (BIIB) stock has taken an uptrend, with the latest gain ...
Read moreRegardless of the heated debates on the drug’s efficacy, Biogen (BIIB) stock has taken an uptrend, with the latest gain ...
Read moreThe updated vaccine specifically addresses the XBB.1.5 subvariant of the Omicron variant, which has raised concerns due to its potential...
Merck is seeking authorization for emergency use of molnupiravir, an oral administration for early-stage COVID-19 patients. It is in talks...
Regardless of the heated debates on the drug’s efficacy, Biogen (BIIB) stock has taken an uptrend, with the latest gain...
Regardless of the heated debates on the drug’s efficacy, Biogen (BIIB) stock has taken an uptrend, with the latest gain...
© 2018 JNews by Jegtheme.